日本語 
Pharma
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a collaboration that is basically aimed at one thing. Making antibody-drug conjugate work move faster from early development to actual commercial…
Piramal Pharma and Ajinomoto Boost ADC Manufacturing
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a collaboration that…
Taletrectinib Moves Toward Europe Approval Review
Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the…
transcosmos partners Tokyo University on pharmacist gap
Transcosmos established a partnership with Tokyo University of Pharmacy and Life Sciences.…
Curatis Transfers Corticorelin Japan Rights to Neupharma
Curatis Holding AG has signed an exclusive licensing and development agreement with…
CMIC adopts Bluenote AI to streamline Trial Documentation
CMIC Co., Ltd., a contract research organization jointly owned by Blackstone and…
Hitachi and Shionogi deploy genAI in drug regulatory work
Hitachi, Ltd. has entered a licensing agreement with Shionogi & Co., Ltd.…
Astella and Vir Biotechnology sign global deal for VIR-5500
Astellas Pharma Inc. and Vir Biotechnology, Inc. are teaming up globally to…
Japan Authorizes First iPS Cell-Derived Therapies, Marking Breakthrough in Regenerative Medicine
Japan is at the forefront of healthcare innovation by becoming the first…
Piramal Pharma and Ajinomoto Boost ADC Manufacturing
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a collaboration that…
Taletrectinib Moves Toward Europe Approval Review
Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the…
transcosmos partners Tokyo University on pharmacist gap
Transcosmos established a partnership with Tokyo University of Pharmacy and Life Sciences.…
Curatis Transfers Corticorelin Japan Rights to Neupharma
Curatis Holding AG has signed an exclusive licensing and development agreement with…
CMIC adopts Bluenote AI to streamline Trial Documentation
CMIC Co., Ltd., a contract research organization jointly owned by Blackstone and…
Hitachi and Shionogi deploy genAI in drug regulatory work
Hitachi, Ltd. has entered a licensing agreement with Shionogi & Co., Ltd.…
Astella and Vir Biotechnology sign global deal for VIR-5500
Astellas Pharma Inc. and Vir Biotechnology, Inc. are teaming up globally to…
Japan Authorizes First iPS Cell-Derived Therapies, Marking Breakthrough in Regenerative Medicine
Japan is at the forefront of healthcare innovation by becoming the first…
English